IL1RN and inflammatory bowel disease: Based on the above results, we could preliminarily draw the following conclusion: Transcription factor ELF4 may alleviate inflammatory bowel disease by activating IL1RN transcription to suppress the inflammatory activity of TH17 cells and inducing M2 polarization of macrophages (Figure 6).